Quick Answer
LIXTE BIOTECHNOLOGY HOLDINGS, INC. reported Net Income of -$6.08 million for fiscal year 2025.
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$6.08M | -69.5% |
| 2024 | -$3.59M | +29.5% |
| 2023 | -$5.09M | +19.4% |
| 2022 | -$6.31M | +6.2% |
| 2021 | -$6.73M | -106.1% |
| 2020 | -$3.26M | -33.8% |
| 2019 | -$2.44M | -14.4% |
| 2018 | -$2.13M | -18.0% |
| 2017 | -$1.81M | +15.3% |
| 2016 | -$2.13M | +25.2% |
| 2015 | -$2.85M | -3.1% |
| 2014 | -$2.77M | -101.2% |
| 2013 | -$1.37M | +61.6% |
| 2012 | -$3.58M | -73.1% |
| 2011 | -$2.07M | -134.9% |
| 2010 | -$880.2K | +43.3% |
| 2009 | -$1.55M | -22.0% |
| 2008 | -$1.27M | +22.9% |
| 2007 | -$1.65M | -193.3% |
| 2006 | -$562.1K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.98M | -100.8% | -155.3% |
| June 30, 2025 | -$775.7K | +23.3% | -9.3% |
| March 31, 2025 | -$709.6K | +26.9% | +28.0% |
| September 30, 2024 | -$986.0K | +3.2% | +2.5% |
| June 30, 2024 | -$1.01M | +39.4% | -4.1% |
| March 31, 2024 | -$971.3K | +29.0% | +4.7% |
| September 30, 2023 | -$1.02M | +31.1% | +38.9% |
| June 30, 2023 | -$1.67M | -7.9% | -22.0% |
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. showed a decrease of -69.5% in Net Income compared to the prior fiscal year.
- Over the 2006–2025 period, LIXTE BIOTECHNOLOGY HOLDINGS, INC.’s net income has declined by 981.4% (from -$562.1 thousand to -$6.08 million).
- The most recent figure is from LIXTE BIOTECHNOLOGY HOLDINGS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: